Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy complications in hematological diseases

G J Ruiz-Argüelles1, B M Velázquez, R Pérez-Tamayo

  • 1Centro de Hematología y Medicina Interna de Puebla, México.

Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|November 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eco-epidemiological clustering and cluster-wise forecasting of dengue in Mexico, 2020-2025.

Acta tropica·2026
Same author

Generation and characterization of an ovine cell line derived from peripheral blood and its potential use in the study of livestock and zoonotic viral infections.

Virology journal·2025
Same author

Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center.

Clinical and experimental immunology·2019
Same author

The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.

Bone marrow transplantation·2016
Same author

Congenital Acute Megakaryoblastic Leukaemia in Down's Syndrome.

Leukemia & lymphoma·2016
Same author

Are there "Attenuated" Forms of Evans Syndrome?

Hematology (Amsterdam, Netherlands)·2016

Splenectomy for hematological diseases carries a 27% complication risk, significantly higher in malignant cases (83%). Spleen size and early age impact complication rates, necessitating careful risk-benefit assessment.

Area of Science:

  • Medicine
  • Hematology
  • Surgery

Background:

  • Splenectomy is a procedure performed for various hematological conditions.
  • Understanding postoperative complications is crucial for patient management.

Purpose of the Study:

  • To report and analyze postoperative complications in patients with hematological diseases undergoing splenectomy.
  • To identify factors associated with increased complication rates.

Main Methods:

  • Retrospective analysis of 27 patients with hematological diseases who underwent splenectomy.
  • Data collection on patient demographics, hematological condition (malignant vs. non-malignant), spleen size, and postoperative complications.

Main Results:

  • Overall complication rate was 27% (6 out of 27 patients), with a 3% fatal complication rate.

Related Experiment Videos

  • Patients with hematological malignancies had a significantly higher complication rate (83%) compared to those with benign conditions (9%).
  • Larger spleen size (median 990g vs 132g) and splenectomy before six months of age were associated with increased complications.

    • Conclusions:

    • Splenectomy for hematological diseases is associated with significant postoperative risks, particularly in malignant cases.
    • Spleen size and patient age are critical factors influencing complication rates.
    • Careful consideration of risks versus benefits is essential when performing splenectomies for hematological conditions.